Please consult with your medical professional about the applicability of this information to your own situation. The content below includes links to external sites, which will open in a new browser window.
What are vaccines?
Vaccines are immunizations that generally come in the form of shots, and help our bodies to defend against a number of infectious diseases. Vaccines typically contain a killed or much weakened virus or protein that stimulates our body to produce antibodies against a specific disease.
How many vaccines are there?
Currently, there are 27 licensed vaccines in the U.S. to help prevent diseases like tetanus, polio, influenza, measles, mumps, hepatitis and HPV/cervical cancer.
Can a vaccine cause the disease it is supposed to prevent?
Most of our current vaccines are inactivated (killed), so that they cannot cause disease. A few vaccines use weakened or attenuated viruses, so they could theoretically cause disease, but generally do not.
What kinds of vaccines need to be studied?
There are several vaccines in development for treating diseases like bird flu, anthrax, tuberculosis and malaria. The hope is to find a bird flu vaccine that doesn’t depend on chicken embryos for its manufacturing, so that hundreds of millions of doses could be quickly produced in the event of a global outbreak of bird flu. We call our volunteers “everyday heroes” because they help to come up with solutions to some of the world’s biggest problems, such as the threat of pandemic bird flu.
Vaccine Studies in Rochester, NY
Rochester Clinical Research is currently enrolling generally healthy individuals over 50 years old for a vaccine research study. The study will assess the safety and tolerability of two different dosage levels of study vaccine that may protect against a greater number of strains of pneumococcal disease. The study will last approximately 6 months with two visits to our office and 3 telephone calls. View Trial Details
Rochester Clinical Research is currently enrolling individuals over the age of 60 years old, who have had a UTI within the past 5 years for an E. coli vaccine research study. The study will evaluate the effectiveness of a stud vaccine that may protect against E. coli that could cause sepsis. View Trial Details
Rochester Clinical Research is following the ever-changing impact of the Coronavirus on a national level and in our local community. Please review our COVID Reopening Patient Access. View Trial Details
Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the study Chikungunya vaccine in healthy adults over the age of 18 years old. View Trial Details
The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45. The vaccine aims to prevent HPV infection which are associated with oral cancer. Compensation is available up to $1,300, for those who qualify. View Trial Details
For more information on vaccines:
Mayo Clinic: Top 5 Myths about Vaccines